Pacific Biosciences of California PACB Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's short- and long-term operating lease liabilities?
- Pacific Biosciences of California (PACB) reported short- and long-term operating lease liabilities of $1.43M in Q1 2026.
- How has Pacific Biosciences of California's short- and long-term operating lease liabilities changed year-over-year?
- Pacific Biosciences of California's short- and long-term operating lease liabilities increased by 188.1% year-over-year, from -$1.62M to $1.43M.
- What is the long-term trend for Pacific Biosciences of California's short- and long-term operating lease liabilities?
- Over 3 years (2022 to 2025), Pacific Biosciences of California's short- and long-term operating lease liabilities has grown at a -54.6% compound annual growth rate (CAGR), from -$7.72M to $723K.